Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.
about
High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancerHow to calculate the dose of chemotherapyGene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancerRandomized trials of high-dose chemotherapy in breast cancer: fraud, the press and the data (or lessons learned in medical policy governing clinical research).Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999.High-dose mitoxantrone and cyclophosphamide without stem cell support in patients with high-risk and advanced breast carcinoma: a Phase II multicentric trial.Outcome of 67 patients with solid tumors relapsed after high-dose chemotherapy and peripheral blood stem cell transplantation.Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term resultsClinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-positive breast cancer (summary of the 2001 update). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of BrIs Higher Efficacy Always at the Price of More Side Effects during Chemotherapy?High-dose chemotherapy followed by autologous stem cell transplantation as a first-line therapy for high-risk primary breast cancer: a meta-analysis.Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue.High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.Neutrophil-guided dosing of anthracycline-cyclophosphamide-containing chemotherapy in patients with breast cancer: a feasibility study.Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer.Sequential methods and group sequential designs for comparative clinical trials.Cardiac toxicity of high-dose chemotherapy.High-dose therapy for breast cancer - a case of suspended animation.A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIGN-terminal pro-brain natriuretic peptide as an early prognostic factor in cancer patients developing septic shockA nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities.High-dose chemotherapy for male germ cell tumor.Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective studyThe analysis of relapse-free survival curves: implications for evaluating intensive systemic adjuvant treatment regimens for breast cancerNeutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin, oxaliplatin and 5-fluorouracil regimen.Block sequential adriamycin CMF--optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer.Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial.Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapyToxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute experience.Do anthracyclines still have a role in adjuvant chemotherapy of breast cancer?Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001-2009).Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients.Five-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancer.Symptom distress, functional status and health-related quality of life before high-dose chemotherapy with stem-cell transplantation.High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation for High-Risk Primary Breast Cancer.Pretreated baseline neutrophil count and chemotherapy-induced neutropenia may be conveniently available as prognostic biomarkers in advanced gastric cancer.Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients.Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantation.
P2860
Q24246510-6CA4E684-935E-4447-B151-FE2B0094C924Q24642872-C18D9310-9C0A-437A-BBED-8691308DAE58Q25257621-D6FD6EE4-0840-4142-B9B8-C05C3D4F40A3Q26471974-8AAE05DF-623E-48E4-B597-05C9C824006BQ30696719-49A7C9B3-9E87-4316-8B31-6137DD051F7EQ30820946-7A372F3B-AD94-4223-B302-FE941F82E0DDQ33340182-2134B110-8B50-4414-9EF7-E3AC1850FAFBQ33348201-32FE4EDB-9857-489D-9160-8C8ECD1C009BQ33397922-20BE2767-DD5E-4C04-8735-5845575910D5Q33955349-A43BC5B1-9C17-4DD5-A777-7BCF00CE53D0Q34095821-8B134CFC-6596-4E10-A019-9AEF7FA2871FQ34200900-D25B1950-AB02-4DAA-9F72-CE93A76C3C5BQ34736588-E4A45F6F-4082-4D77-A879-B0082647F69CQ35065084-90585322-E42A-4889-A5FD-2F51C079AF95Q35171432-82EB6D09-1B31-4B3C-B592-9F86C08067BFQ35212672-C1498782-C767-47B0-B559-BDF60E142B8EQ35619637-138A2741-2170-4F0D-BCFC-F4B0ABCDBA92Q35949084-1D343B69-F2E2-4212-8DC0-30B6E8A78FACQ36306186-E6888781-FDDC-41AD-BD8B-19023EC30D64Q36347386-A493E214-6B16-4FF9-BDB2-86BE4F4C4892Q36392546-854CAE46-8D40-434E-8272-BE13988563C4Q36409909-AB59AA9D-3C96-4841-A846-00743116AFC1Q36563573-D6B67C48-46A2-49D3-9463-AA37667651B4Q36613992-33DE9674-8208-4994-B4C8-EBDAEE1A73B5Q36615818-D070E7B9-C643-4EA6-9D1E-64FDEA860904Q36629488-C2C626CB-6823-4040-BAF5-E3B84E3CFB58Q36646508-76747D0F-C655-4E77-BE2B-6D8C34985A4CQ36671677-B894074E-7225-4272-8EC5-984B93D8DB03Q37049920-1E333E57-325F-402A-BBD7-F4011959432CQ37259756-9868D352-247B-441E-92DA-2C791F46E582Q37340528-C9BCDB63-050A-4C60-AA9A-938F5BD3CCAEQ37822734-3C7D3486-4F97-4FD7-BDD8-8662FFC201F0Q37827010-946548E8-357B-40D3-8AD8-B2EB761661DBQ38040419-28C996B6-648B-4669-AF91-55AF2B88A8BCQ40492547-2C1DDF2F-5256-4156-8DB1-10BADC372E38Q40563373-73AF11F3-9667-4F35-86F5-ABF3A698D114Q40847140-34C49D97-C1EB-4683-AA9C-E2AA2744E1CDQ41076006-3CD0DA8D-FE6F-408C-9482-07A1A9A44688Q43583135-96A02AC6-F44C-4C13-A7FA-6DE4F0943EE7Q44012468-14DEB1CF-808A-4D1A-B3B3-C3DD7207A874
P2860
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Tailored fluorouracil, epirubi ...... avian Breast Group 9401 study.
@en
Tailored fluorouracil, epirubi ...... avian Breast Group 9401 study.
@nl
type
label
Tailored fluorouracil, epirubi ...... avian Breast Group 9401 study.
@en
Tailored fluorouracil, epirubi ...... avian Breast Group 9401 study.
@nl
prefLabel
Tailored fluorouracil, epirubi ...... avian Breast Group 9401 study.
@en
Tailored fluorouracil, epirubi ...... avian Breast Group 9401 study.
@nl
P2093
P1433
P1476
Tailored fluorouracil, epirubi ...... avian Breast Group 9401 study.
@en
P2093
B Erikstein
E Lidbrink
E Salminen
G Söderlund
P304
P356
10.1016/S0140-6736(00)02841-5
P407
P577
2000-10-01T00:00:00Z